To compare the effects of INSTIs with those of NNRTIs or PIs on the development of metabolic comorbidities in patients with HIV, the researchers retrospectively studied 206 incarcerated adults with HIV who received a guideline-recommended antiretroviral therapy.
To explore factors associated with gaining weight in patients with HIV receiving ART, the researchers retrospectively studied a cohort of 870 adult patients with HIV who were seen for at least 3 months at the Wexner Medical Center Infectious Diseases Clinic.
The researchers conducted this analysis to benchmark influenza vaccination rates among their patients at a single center in Wilmington, Delaware, and compared them with national influenza vaccination rates.
In this podcast, Niha Idrees, PharmD, and Melissa Badowski, PharmD, MPH, BCIDP, speak about their team's research evaluating the incidence of hypertension, diabetes, and hyperlipidemia in patients on INSTI-based regimens compared with NNRTI-based and PI-based regimens. They also talk about weight gain and obesity in patients living with HIV. They presented on these topics at ID Week 2021.